Tivozanib Induces Durable Response Among Patients with Advanced Renal Cell Carcinoma

The VEGF TKI induced durable responses and favorable tolerability in patients with relapsed/refractory RCC.

Source: CancerNetwork - May 20, 2020 Category: Cancer & Oncology Authors: Kristie L. Kahl Source Type: news